Justin Bowers
Stock Analyst at Deutsche Bank
(1.75)
# 3,096
Out of 4,847 analysts
49
Total ratings
35.48%
Success rate
1.06%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $349.39 | -6.98% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $142.78 | +85.60% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $4.63 | +396.76% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.66 | +33.89% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $94.44 | +6.95% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $306.08 | +9.78% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $9.11 | +174.42% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $124.61 | +24.39% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $399.93 | +52.53% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $48.78 | +68.10% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $13.15 | +90.11% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.23 | +662.33% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $133.76 | +124.28% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $192.06 | +43.18% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $210.64 | +18.69% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $138.49 | +109.40% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $15.31 | +200.46% | 5 | May 10, 2021 | |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $349.39
Upside: -6.98%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $142.78
Upside: +85.60%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $4.63
Upside: +396.76%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.66
Upside: +33.89%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $94.44
Upside: +6.95%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $306.08
Upside: +9.78%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $9.11
Upside: +174.42%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $124.61
Upside: +24.39%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $399.93
Upside: +52.53%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $48.78
Upside: +68.10%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $13.15
Upside: +90.11%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.23
Upside: +662.33%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $133.76
Upside: +124.28%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $192.06
Upside: +43.18%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $210.64
Upside: +18.69%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $138.49
Upside: +109.40%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $15.31
Upside: +200.46%